1-1 of 1
Catherine D. Richardson, RN, MSN
Close
Save search
Sort by
Journal Articles

Phase II Evaluation of Sunitinib Malate, a Multi-Targeted Inhibitor of Receptor Tyrosine Kinases, in Patients with Myelofibrosis.

Free
Constantine S. Tam, MBBS, Deborah A. Thomas, MD, Farhad Ravandi, MD, Catherine D. Richardson, RN, MSN, Gautam Borthakur, MD, Jan A. Burger, MD, Elihu Estey, MD, Hagop Kantarjian, MD, Srdan Verstovsek, MD
Journal: Blood
Blood (2007) 110 (11): 3552.
https://doi.org/10.1182/blood.V110.11.3552.3552
Published: 2007